Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Medical Specialties
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific, Inc. | -1.14% | 548.86 | 1.0% | $904.15m | |
| DHR | Danaher Corp. | -0.38% | 252.16 | 0.7% | $718.28m | |
| ABT | Abbott Laboratories | -1.01% | 113.87 | 0.8% | $652.99m | |
| ISRG | Intuitive Surgical, Inc. | -1.45% | 218.39 | 0.8% | $517.56m | |
| MDT | Medtronic Plc | 1.29% | 105.60 | 0.6% | $491.01m | |
| BSX | Boston Scientific Corp. | 0.63% | 40.14 | 1.0% | $397.53m | |
| ALGN | Align Technology, Inc. | -3.06% | 270.18 | 6.4% | $372.96m | |
| SYK | Stryker Corp. | 0.29% | 233.72 | 1.3% | $354.68m | |
| IDXX | IDEXX Laboratories, Inc. | -1.68% | 362.16 | 3.8% | $340.47m | |
| BDX | Becton, Dickinson & Co. | 0.23% | 257.60 | 1.0% | $319.47m | |
| EW | Edwards Lifesciences Corp. | -1.72% | 94.48 | 0.4% | $301.32m | |
| DXCM | DexCom, Inc. | -11.05% | 288.13 | 7.7% | $275.83m | |
| A | Agilent Technologies, Inc. | -0.99% | 124.73 | 1.6% | $264.35m | |
| BAX | Baxter International, Inc. | 0.83% | 73.98 | 1.8% | $241.38m | |
| MTD | Mettler-Toledo International, Inc. | -1.25% | 1231.91 | 5.8% | $193.85m |
Company Profile
MAP Pharmaceuticals, Inc., a development stage company, focuses on developing novel inhalation therapies for respiratory and systemic diseases. It has various proprietary product candidates in clinical development, including Unit Dose Budesonide for pediatric asthma in children from six months to eight years of age and MAP0004 for migraine. The company's product portfolio also includes MAP0005 for the treatment of adolescent and adult asthma, and chronic obstructive pulmonary disease; and MAP0001 for the treatment of Type 1 and Type 2 diabetes via pulmonary delivery using its Tempo inhaler. MAP Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Mountain View, California.